These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 6328010

  • 1. Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.
    Glorioso J, Schröder CH, Kumel G, Szczesiul M, Levine M.
    J Virol; 1984 Jun; 50(3):805-12. PubMed ID: 6328010
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J, Szczesiul MS, Marlin SD, Levine M.
    Virology; 1983 Apr 15; 126(1):1-18. PubMed ID: 6189286
    [Abstract] [Full Text] [Related]

  • 3. Herpes simplex virus glycoproteins: isolation of mutants resistant to immune cytolysis.
    Machtiger NA, Pancake BA, Eberle R, Courtney RJ, Tevethia SS, Schaffer PA.
    J Virol; 1980 May 15; 34(2):336-46. PubMed ID: 6246268
    [Abstract] [Full Text] [Related]

  • 4. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J, Kees U, Kümel G, Kirchner H, Krammer PH.
    J Immunol; 1985 Jul 15; 135(1):575-82. PubMed ID: 2582051
    [Abstract] [Full Text] [Related]

  • 5. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA, Marlin SD, Schwartz SA, Glorioso JC.
    J Immunol; 1984 Oct 15; 133(4):2206-14. PubMed ID: 6206157
    [Abstract] [Full Text] [Related]

  • 6. Herpes simplex virus glycoproteins: participation of individual herpes simplex virus type 1 glycoprotein antigens in immunocytolysis and their correlation with previously identified glycopolypeptides.
    Norrild B, Shore SL, Nahmias AJ.
    J Virol; 1979 Dec 15; 32(3):741-8. PubMed ID: 229263
    [Abstract] [Full Text] [Related]

  • 7. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
    Rosenthal KL, Smiley JR, South S, Johnson DC.
    J Virol; 1987 Aug 15; 61(8):2438-47. PubMed ID: 3037106
    [Abstract] [Full Text] [Related]

  • 8. Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
    Kümel G, Kaerner HC, Levine M, Schröder CH, Glorioso JC.
    J Virol; 1985 Dec 15; 56(3):930-7. PubMed ID: 2415719
    [Abstract] [Full Text] [Related]

  • 9. Genetic and phenotypic analysis of herpes simplex virus type 1 mutants conditionally resistant to immune cytolysis.
    Pancake BA, Aschman DP, Schaffer PA.
    J Virol; 1983 Sep 15; 47(3):568-85. PubMed ID: 6312082
    [Abstract] [Full Text] [Related]

  • 10. Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD.
    Dix RD, Mills J.
    J Med Virol; 1985 Sep 15; 17(1):9-18. PubMed ID: 2995573
    [Abstract] [Full Text] [Related]

  • 11. Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.
    Marlin SD, Highlander SL, Holland TC, Levine M, Glorioso JC.
    J Virol; 1986 Jul 15; 59(1):142-53. PubMed ID: 2423702
    [Abstract] [Full Text] [Related]

  • 12. Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis.
    Glorioso JC, Levine M, Holland TC, Szczesiul MS.
    J Virol; 1980 Sep 15; 35(3):672-81. PubMed ID: 6252331
    [Abstract] [Full Text] [Related]

  • 13. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL, Duncan BE, Raybould TJ, Watson DH.
    J Gen Virol; 1985 May 15; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [Abstract] [Full Text] [Related]

  • 14. Alterations in glycoprotein gB specified by mutants and their partial revertants in herpes simplex virus type 1 and relationship to other mutant phenotypes.
    Haffey ML, Spear PG.
    J Virol; 1980 Jul 15; 35(1):114-28. PubMed ID: 6251260
    [Abstract] [Full Text] [Related]

  • 15. Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
    Holland TC, Marlin SD, Levine M, Glorioso J.
    J Virol; 1983 Feb 15; 45(2):672-82. PubMed ID: 6187935
    [Abstract] [Full Text] [Related]

  • 16. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.
    Hendricks RL, Tao MS, Glorioso JC.
    J Immunol; 1989 Jan 01; 142(1):263-9. PubMed ID: 2909617
    [Abstract] [Full Text] [Related]

  • 17. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
    Dix RD, Pereira L, Baringer JR.
    Infect Immun; 1981 Oct 01; 34(1):192-9. PubMed ID: 6271681
    [Abstract] [Full Text] [Related]

  • 18. Estimation of the B lymphocyte precursor frequencies to herpes simplex type 1 glycoproteins by a limiting dilution assay.
    Turtinen LW, Lathey JL, Rouse BT.
    J Med Virol; 1986 Dec 01; 20(4):357-62. PubMed ID: 3025354
    [Abstract] [Full Text] [Related]

  • 19. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice.
    Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL.
    J Virol; 1994 Apr 01; 68(4):2118-26. PubMed ID: 8138996
    [Abstract] [Full Text] [Related]

  • 20. Preparation and characterization of specific antisera to individual glycoprotein antigens comprising the major glycoprotein region of herpes simplex virus type 1.
    Eberle R, Courtney RJ.
    J Virol; 1980 Sep 01; 35(3):902-17. PubMed ID: 6252346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.